Evaluation of the Efficacy of Manual Therapy, Therapeutic Exercise and the Two Modalities Combined in Pain Reduction in Patients With Headache
1 other identifier
interventional
100
1 country
1
Brief Summary
The study aims to evaluate which is the best approach for the non-pharmacological treatment of patients with different types of primary headaches (tension-type headache (TTC), trigeminal autonomic headache (TACs) and migraine) or cervicogenic headache by comparing three methods of intervention to control treatment (drug therapy): therapeutic exercise (TE), myofascial release + TE, and Mulligan's manual therapy + TE. The efficacy will be evaluated in terms of reduction of headache episodes, pain intensity and its duration.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 5, 2023
CompletedFirst Submitted
Initial submission to the registry
May 29, 2023
CompletedFirst Posted
Study publicly available on registry
August 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2026
CompletedAugust 14, 2023
August 1, 2023
1.8 years
May 29, 2023
August 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Headache frequency
number of headache attacks in one month
4 weeks (end of treatment)
Headache frequency
number of headache attacks in one month
3 months after the end of the treatment
Headache frequency
number of headache attacks in one month
6 months after the end of the treatment
Secondary Outcomes (24)
Headache clinical presentation
4 weeks (end of treatment)
Headache clinical presentation
3 months after the end of the treatment
Headache clinical presentation
6 months after the end of the treatment
Headache related disability
4 weeks (end of treatment)
Headache related Disability
3 months after the end of the treatment
- +19 more secondary outcomes
Study Arms (4)
Myofascial Release (MR) + Therapeutic exercise (TE)
EXPERIMENTALPatients in the MR+TE group will undergo 12 sessions (3 d/week) of sub-occipital inhibition treatment as a combined muscle and soft tissue inhibition technique. The physiotherapist will apply deep pressure which will be maintained for a total of 10 minutes until the sub-occipital tissues are released. In addition to this technique, the method of pumping and manual treatment (acupressure) of the trigger points on the sub-occipital muscles, on the upper bundles of the trapezius bilaterally, on the sternocleidomastoid bilaterally and on the scalene muscles bilaterally will be applied for a further 10 minutes for a total treatment with myofascial release equal to 20 minutes. At the end of the MR session, the 20-minute TE session will be performed in the same way as described in the TE intervention group.
Manual therapy (MT) + Therapeutic exercise (TE)
EXPERIMENTALThe MT+TE intervention group will carry out rehabilitation treatment with a structured protocol based on mobilizations according to the Mulligan method. Treatment according to Mulligan will be carried out at the discretion of the therapist on the basis of daily evaluations of cervical dysfunction and the eventual manifestation of headache. 5 different techniques will be performed on the patient in 12 sessions (3 v/week, for 4 weeks) as described in Satpute, K., Bedekar, N. \& Hall, T. Effectiveness of Mulligan manual therapy over exercise on headache frequency, intensity and disability for patients with migraine, tension-type headache and cervicogenic headache - a protocol of a pragmatic randomized controlled trial. BMC Musculoskelet Disord 22, (2021)..
Therapeutic exercise (TE)
EXPERIMENTALPatients in the TE intervention group will be asked to perform 12 sessions (3 day/week) of TE supervised by a physiotherapist. Each session will have a total duration of 40 min divided into 20 min of aerobic exercise and 20 min of TE. Aerobic exercise consists of a total of 20 min of activity on a stationary bike using parameters to increase performance (intensity over 20 min) progressively based on fatigue (Borg scale).The TE consists of warm-up and cool-down exercises for the cervical ROM, associated with stretching exercises of the cervical and scapulothoracic muscles. After the warm-up, muscle strengthening exercises will be performed (isometric, concentric and eccentric contractions of the cervical muscles).
Control
ACTIVE COMPARATORPatients assigned to the control group will follow the pharmacological treatment according to medical doctor indications (clinical practice).
Interventions
Myofascial release therapy is a type of gentle, constant massage that releases tightness and pain throughout myofascial tissues.
drug treatment according to the medical indications of clinical practice
The manual therapy consists of the concurrent application of sustained accessory mobilization applied by a therapist and an active physiological movement to end range applied by the patient. Passive end-of-range overpressure, or stretching, is then delivered without pain as a barrier.
The ET consists of an initial phase of aerobic exercise (cyclette), subsequently the intervention foresees exercises for the cervical ROM, stretching exercises of the cervical and scapulothoracic muscles and muscle strengthening exercises (isometric, concentric and eccentrics of the cervical musculature).
Eligibility Criteria
You may qualify if:
- Patients suffering from primary headache or cervicogenic headache;
- Age \> 18 years;
- signature of the informed consent.
You may not qualify if:
- upper cervical spine instability;
- cervical arterial insufficiency
- cervical spine fractures
- pregnancies
- rheumatoid arthritis
- severe cognitive impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rehabilitation Department Fondazione Policlinico Universitario Campus Bio-Medico
Roma, RM, 00128, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Silvia Sterzi, MD
Fondazione Policlinico Universitario Campus Bio-Medico
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- the assessor is unaware of the type of treatment the patients have received
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Physical Medicine and Rehabilitative Unit
Study Record Dates
First Submitted
May 29, 2023
First Posted
August 14, 2023
Study Start
April 5, 2023
Primary Completion
February 1, 2025
Study Completion
April 1, 2026
Last Updated
August 14, 2023
Record last verified: 2023-08